55.25p-2.25 (-3.91 %)19 Jan 2021, 14:37
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Redx Pharma PLC Fundamentals

Company NameRedx Pharma PLCLast Updated2021-01-19
IndustryBiotechnologySectorHealthcare
Shares in Issue273.887 mMarket Cap£151.32 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.03EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.4631Debt Equity Ratio1.5648
Asset Equity Ratio3.8488Cash Equity Ratio0.8555
Quick Ratio1.1484Current Ratio1.45
Price To Book Value0ROCE0

Redx Pharma PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Redx Pharma PLC Company Financials

Assets20192018
Tangible Assets£134,000.00£191,000.00
Intangible Assets£417,000.00£423,000.00
Investments00
Total Fixed Assets£551,000.00£614,000.00
Stocks00
Debtors£445,000.00£818,000.00
Cash & Equivalents£3.70 m£6.47 m
Other Assets00
Total Assets£6.36 m£10.32 m
Liabilities20192018
Creditors within 1 year£4.87 m£3.95 m
Creditors after 1 year0£605,000.00
Other Liabilities00
Total Liabilities£4.87 m£4.55 m
Net assets£1.49 m£5.76 m
Equity20192018
Called up share capital£1.26 m£1.26 m
Share Premium£33.26 m£33.26 m
Profit / Loss-£6.33 m-£10.15 m
Other Equity£1.49 m£5.76 m
Preference & Minorities00
Total Capital Employed£1.49 m£5.76 m
Ratios20192018
Debt Ratio00
Debt-to-Equity00
Assets / Equity3.84883.8488
Cash / Equity0.85550.8555
EPS-£0.04-£0.06
Cash Flow20192018
Cash from operating activities-£4.67 m-£17.18 m
Cashflow before financing-£2.80 m-£17.23 m
Increase in Cash-£2.77 m-£17.34 m
Income20192018
Turnover£3.13 m£129,000.00
Cost of sales£350,000.000
Gross Profit£2.78 m£129,000.00
Operating Profit-£6.25 m-£10.17 m
Pre-Tax profit-£6.33 m-£10.15 m

Redx Pharma PLC Company Background

SectorHealthcare
ActivitiesRedx Pharma PLC is a UK biotechnology company whose vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.
Latest Interim Date30 Jun 2020
Latest Fiscal Year End Date27 Jan 2021

Redx Pharma PLC Directors

AppointedNamePosition
2020-12-21Mr. Iain Gladstone RossNon-Executive Director,Chairman
2018-02-19Dr. Frank Murdoch ArmstrongNon-Executive Director,Chairman
2020-12-21Mr. Peter Eric Presland Non-Executive Director
2018-02-19Mr. Norman MolyneuxNon-Executive Director
2018-02-19Dr. Neil David MurrayExecutive Director,Chief Executive Officer
2018-02-19Dr. Peter JacksonNon-Executive Director
2017-03-30Dr. Derek LindsayExecutive Director,Chief Operating Officer
2017-03-30Mr. Philip John TotteyExecutive Director,Chief Financial Officer
2017-04-20Mr. Peter McPartlandNon-Executive Director
2020-01-09Dr. Bernhard Jurgen KirschbaumNon-Executive Director
2020-03-17Mr. Dominic Nicholas Jackson Executive Director,Chief Financial Officer
2020-12-23Ms. Lisa Mary Whewell AnsonExecutive Director,Chief Executive Officer
2020-06-30Dr. James Robert MeadExecutive Director,Chief Financial Officer
2020-12-21Ms. Sarah Gordon WildNon-Executive Director

Redx Pharma PLC Contact Details

Company NameRedx Pharma PLC
AddressBlock 33, Mereside, Alderley Park, Macclesfield, SK10 4TG
Telephone+44 1625469900
Websitehttp://www.redxpharma.com

Redx Pharma PLC Advisors

StockbrokerWG Partners
Financial PR AdviserConsilium Strategic Communications
Phone+44 2037095700
Nominated AdviserCantor Fitzgerald Europe
Phone +44 2078947895
StockbrokerCantor Fitzgerald Europe
Phone+44 2078947895
SolicitorDWF LLP
Phone+44 1612283702
Fax+44 1618352407
RegistrarEquiniti Ltd.
Phone+44 1214157082